For this, the edited T cells were co-incubated together with ML-2 acute myeloid leukemia (AML) cells that endogenously present the myeloperoxidase peptide, and which were transgenic for HLA-B7 or control HLA-B15 (Mall et al, 2016). This evidence concerns the gene MPO and acute myeloid leukemia.